CX Institutional’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1K Sell
50
-142
-74% -$1.7K ﹤0.01% 1540
2026
Q1
$1K Buy
192
+1
+0.5% +$8 ﹤0.01% 1523
2025
Q4
$1K Sell
191
-269
-58% -$2.13K ﹤0.01% 1478
2025
Q3
$5K Buy
460
+70
+18% +$687 ﹤0.01% 1263
2025
Q2
$4K Hold
390
﹤0.01% 1116
2025
Q1
$6K Buy
+390
New +$6K ﹤0.01% 1054
2022
Q3
Sell
-1,430
Closed -$48K 931
2022
Q2
$48K Buy
+1,430
New +$50.1K ﹤0.01% 683
2021
Q4
Sell
-1,161
Closed -$38K 741
2021
Q3
$38K Sell
1,161
-1,111
-49% -$35.5K ﹤0.01% 635
2021
Q2
$69K Buy
+2,272
New +$74.8K 0.01% 501

Other funds holding OGN

CX Institutional's OGN Position: Q2 2026 in Review

CX Institutional reduced its Organon & Co (OGN) stake by 74% in Q2 2026, selling an estimated $1.7K and leaving 50 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1540.

CX Institutional first reported a position in OGN in Q2 2021 and has held it in 9 quarters since. The position peaked at $69K in Q2 2021. 107 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • CX Institutional held 50 shares of Organon & Co worth $1K as of Q2 2026.
  • CX Institutional sold 142 Organon & Co shares in Q2 2026, an estimated $1.7K.
  • Organon & Co made up ﹤0.01% of CX Institutional's portfolio in Q2 2026, its #1540 holding.
  • CX Institutional first reported a position in Organon & Co in Q2 2021 and has held it in 9 quarters since.
  • CX Institutional's Organon & Co position peaked at $69K in Q2 2021.
  • 107 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.